| 0 (0%) | 04-24 01:20 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1.22 | 1-year : | 1.4 |
| Resists | First : | 1.05 | Second : | 1.2 |
| Pivot price | 0.99  |
|||
| Supports | First : | 0.81 | Second : | 0.67 |
| MAs | MA(5) : | 0.87 |
MA(20) : | 1.02 |
| MA(100) : | 1.29 |
MA(250) : | 1.55 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 9.6 |
D(3) : | 10.6 |
| RSI | RSI(14): 35.1 |
|||
| 52-week | High : | 2.54 | Low : | 0.81 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ DNA ] has closed above bottom band by 20.3%. Bollinger Bands are 5.7% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 0.93 - 0.94 | 0.94 - 0.94 |
| Low: | 0.82 - 0.83 | 0.83 - 0.83 |
| Close: | 0.86 - 0.87 | 0.87 - 0.88 |
Mon, 12 Feb 2024
Metazoans in the DNAi Club - The Scientist
Fri, 11 Aug 2023
DNAi-peptide nanohybrid smart particles target BCL-2 oncogene and induce apoptosis in breast cancer cells - ScienceDirect.com
Wed, 08 Sep 2021
Meet Mullah Hassan Akhund, the head of Taliban's new government in Afghanistan - DNA India
Fri, 10 Mar 2017
DNA interference-mediated screening of maternal factors in the chordate Oikopleura dioica | Scientific Reports - Nature.com
Fri, 12 Aug 2016
Battered and bruised, ProNAi Therapeutics drops PNT2258 completely - Fierce Biotech
Tue, 01 Dec 2015
Why Scientists Are Making Kill Switches for GMOs - Scientific American
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 1,650 (M) |
| Shares Float | 1,120 (M) |
| Held by Insiders | 6.7 (%) |
| Held by Institutions | 83.3 (%) |
| Shares Short | 270,830 (K) |
| Shares Short P.Month | 255,720 (K) |
| EPS | -0.47 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.55 |
| Profit Margin | 0 % |
| Operating Margin | -515.6 % |
| Return on Assets (ttm) | -21.9 % |
| Return on Equity (ttm) | -63.1 % |
| Qtrly Rev. Growth | -64.6 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0.15 |
| EBITDA (p.s.) | -0.41 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -296 (M) |
| Levered Free Cash Flow | -116 (M) |
| PE Ratio | -1.9 |
| PEG Ratio | -0.2 |
| Price to Book value | 1.58 |
| Price to Sales | 5.71 |
| Price to Cash Flow | -4.87 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|